社交活动与中老年抑郁症之间的关联 脑卒中患者
Zhimei Fang1, Junya Chen1, Juan Deng2
1Jinhua University of Vocational Technology, Jinhua City, China.
International journal of behavioral medicine
|February 13, 2026
概括
参与各种社会活动,如与朋友互动和帮助他人,显著减少了中国中风幸存者的抑郁症. 这种社会参与对男性和那些有特定家庭照顾角色的人来说尤其有益.
科学领域:
- 老年学是指老年学的学科.
- 公共卫生 公共卫生
- 精神病学是一个精神病学.
背景情况:
- 脑卒中后抑郁症是一种常见的并发症,影响中风幸存者的结果.
- 参与社会活动是抑郁症的潜在干预措施,但对中国老年人中风患者的证据有限.
研究的目的:
- 研究社会活动参与和多样性与抑郁症之间的关联.
- 为了检查中老年和老年中国中风患者的这些关联.
主要方法:
- 利用了2018年和2020年中国健康与退休长度研究 (CHARLS) 的数据.
- 包括731名中风患者进行横截面分析和365名纵向分析.
- 采用加权后勤回归和子组分析,用于稳定性和差异效应.
主要成果:
- 与朋友互动和帮助他人与横截面的抑郁症可能性降低有关.
- 纵向分析显示,与朋友互动,帮助他人,以及使用互联网减少了发生抑郁的事件.
- 多样化的社会活动参与与显著降低抑郁和抑郁事件的几率有关,特别是在男性中.
结论:
- 参与社会活动,特别是多元化参与,与中国老年中风患者抑郁症的减少有显著的关联.
- 研究结果建议将社会活动纳入中风后康复和心理健康计划.
- 阳性影响在男性中更为明显.
相关概念视频
Pharmacodynamics in Geriatric Patients: Effects of Age
242
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
242
Social Proof
32.4K
Social proof is a form of persuasion based on comparison and conformity. People compare their behavior and actions to what others are doing and will change to conform to do what their peers do.
32.4K
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
717
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
717
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
267
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
267
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
227
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
227
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
261
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
261


